Sudeep Pharma Ltd.

₹966.2

4.2 (0.4%)

SUDEEPPHRM Share Price

Pharmaceuticals & Biotechnology

As on October 23, 2026

SectorNA

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 10,889.9 Cr

P/E Ratio63.12

Dividend Yield0.16 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	980.76	Bearish
10-DMA	1,004.8	Bearish
20-DMA	1,085.65	Bearish
50-DMA	1,139.74	Bearish
100-DMA	991.99	Bearish
200-DMA	810.86	Bullish

Historical Performance

1 Year

N/A

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	6,423	5,020	4,593	4,287	3,430
Total Expenditure	4,195	3,110	2,768	3,386	2,756
Other Income	286	93	61	95	74
Operating Profit	2,514	2,003	1,886	997	748
Interest	85	69	47	58	17
Depreciation	148	106	90	79	45
Profit Before Tax	2,281	1,828	1,748	860	686
Consolidated Net Profit	1,729	1,387	1,332	623	502
Adjusted EPS	15	14	14	6	5

Compounded Sales Growth

10 Years:39.2

5 Years:24.5

3 Years:8.4

TTM:5.1

Compounded Profit Growth

10 Years:57.1

5 Years:39

3 Years:22.6

TTM:4.5

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:N/A

Return on Equity

10 Years:N/A

5 Years:5.2

3 Years:13.7

last year:15.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	113	120	14	14	14
Total Reserves	8,720	4,811	3,546	2,219	1,619
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	743	490	204	255	335
Other Current Liabilities	293	249	252	708	15
Short Term Borrowings	1,021	857	541	518	555
Total Liabilities	11,744	7,168	5,136	4,196	3,438
Capital Work in Progress	1,784	882	447	260	81
Long Term Loans & Advances	131	148	131	51	24
Currents Investments	---	1	1	30	---
Short Term Loans and Advances	562	391	444	481	312
Total Current Assets	6,240	4,241	2,754	2,300	1,966
Total Assets	11,744	7,168	5,136	4,196	3,438
Adjusted Book Value	78	50	37	23	17

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 63.12, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered price CAGR data is unavailable.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹2514 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹6423 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1248078.5

No. of Shares: 1292 (Approx)

Performance:24.8%

248078.5

NIFTY Performance: -12.4%

1 day Top Gainers